Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant

Journal of Molecular Medicine

Volumn 79, Issue 10, 2001, Pages 574-580

  Strazzullo, Pasquale ^a   Iacone, Roberto ^a   Siani, Alfonso ^b   Barba, Gianvincenzo ^b   Russo, Ornella ^a   Russo, Paola ^b   Barbato, Antonio ^a   D'Elia, Lanfranco ^a   Farinaro, Eduardo ^c   Cappuccio, Francesco P ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; cAMP; Glucagon; Hypertension; Natriuresis

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCAGON RECEPTOR; LITHIUM; URIC ACID;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; EVALUATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOTHESIS; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; SODIUM ABSORPTION; TIME; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ADULT; AGED; AMINO ACID SUBSTITUTION; BLOOD PRESSURE; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; LITHIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURESIS; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, GLUCAGON; SODIUM; URIC ACID;

EID: 0034795019     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090100257     Document Type: Article

References (45)

1. Blood pressure control-special role of the kidneys and body fluids
2. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
3. Renal denervation attenuates the sodium retention and hypertension associated with obesity
4. Pathogenesis of weight related changes in blood pressure in dogs
5. Obesity-induced hypertension: Renal function and systemic hemodynamics
6. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion
7. Hypertension, increased aldosterone secretion and low plasma renin activity reversed by dexamethasone
8. An abnormality in steroid metabolism in a hypertensive syndrome
9. Glucagon receptor gene mutation in essential hypertension
10. Hypothesis: Glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension
11. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects
12. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus
13. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon
14. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population
15. Histologic distribution of insulin and glucagon receptors
16. Plasma cAMP: A hepatorenal link influencing proximal reabsorption and renal hemodynamics?
17. Influence of glucagon on GFR and on urea and electrolyte excretion: Direct and indirect effects
18. Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject
19. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats
20. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: The PEGASE study
21. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese
22. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan
23. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population
24. Absence of the Gly40-Ser mutation in the glucagon receptor among diabetic patients in the Netherlands
25. Uric acid metabolism and tubular sodium handling: Results from a population-based study
26. Red blood cell sodium-lithium countertransport and risk of future hypertension. The Olivetti Prospective Heart Study
27. The use of fractional lithium clearance in clinical and epidemiological investigation: A methodological assessment
28. A rapid non-enzymatic method for preparation of HMW DNA from blood for RFLP studies
29. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: Association or founder effect?
30. Small intra- and large inter-individual variability in lithium clearance in humans
31. Evaluation of the lithium clearance method: Direct analysis of tubular lithium handling by micro-puncture
32. Indirect coupling between sodium and urate transport in the proximal tubule
33. Control of uric acid excretion
34. The kidney and uric acid excretion in man
35. ++ transport in cortical and medullary thick ascending limbs of mouse kidney
36. Effects of glucagon on adenosine 3′-5′-monophosphate and guanosine 3′-5′-mono-phosphate in human plasma and urine
37. The sources of plasma cyclic AMP: Studies in the rat using isoprenaline, nicotinic acid and glucagon
38. Excretion and degradation of exogenous adenosine 3′-5′-monophosphate by isolated pre-fused rat kidney
39. The effects of nephrectomy and probenecid on in vivo clearance of adenosine 3′-5′-monophosphate from rat plasma
40. Inhibition by cyclic AMP and dbutyryl cyclic AMP of transport of organic acids in kidney cortex
41. Effect of amino acids on the plasma concentration and urinary excretion of uric acid and uridine
42. Canine kidney glucagon receptor: Evidence for a structurally-different, tissue-specific variant of the glucagon receptor
43. Relative quantitative analysis of glucagon receptor mRNA in rat tissues
44. Splanchnic and renal hemodynamic responses to intraportal infusion of glucagon
45. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension